6-32038462-G-T
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_000500.9(CYP21A2):c.40G>T(p.Ala14Ser) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000766 in 1,566,912 control chromosomes in the GnomAD database, including 1 homozygotes. In-silico tool predicts a benign outcome for this variant. 13/18 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_000500.9 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
CYP21A2 | NM_000500.9 | c.40G>T | p.Ala14Ser | missense_variant | 1/10 | ENST00000644719.2 | NP_000491.4 | |
CYP21A2 | NM_001128590.4 | c.40G>T | p.Ala14Ser | missense_variant | 1/9 | NP_001122062.3 | ||
CYP21A2 | NM_001368143.2 | c.-385G>T | 5_prime_UTR_variant | 1/10 | NP_001355072.1 | |||
CYP21A2 | NM_001368144.2 | c.-295G>T | 5_prime_UTR_variant | 1/9 | NP_001355073.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
CYP21A2 | ENST00000644719.2 | c.40G>T | p.Ala14Ser | missense_variant | 1/10 | NM_000500.9 | ENSP00000496625 | P1 |
Frequencies
GnomAD3 genomes AF: 0.0000197 AC: 3AN: 152138Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.000230 AC: 40AN: 173828Hom.: 1 AF XY: 0.000286 AC XY: 27AN XY: 94492
GnomAD4 exome AF: 0.0000827 AC: 117AN: 1414656Hom.: 1 Cov.: 103 AF XY: 0.000119 AC XY: 83AN XY: 699566
GnomAD4 genome AF: 0.0000197 AC: 3AN: 152256Hom.: 0 Cov.: 32 AF XY: 0.0000269 AC XY: 2AN XY: 74434
ClinVar
Submissions by phenotype
Classic congenital adrenal hyperplasia due to 21-hydroxylase deficiency Uncertain:2
Uncertain significance, criteria provided, single submitter | clinical testing | Fulgent Genetics, Fulgent Genetics | May 11, 2022 | - - |
Uncertain significance, no assertion criteria provided | clinical testing | Lifecell International Pvt. Ltd | - | This variant in exon 1 of the CYP21A2 gene results in the amino acid substitution from Alanine to Serine at codon 14 (p.Ala14Ser) with the sequence change of c.40G>T (NM_000500.7). This variant was observed in a proband with an increased level of 17-OHP enzyme (86.6 nmol/L) which was screened for advanced newborn screening with confirmatory genetic reflex testing at Lifecell Diagnostics. The observed variant is not present in the 1000G database and has a minor allele frequency of 0.0002301 in the gnomAD database. The in-silico predictions by MutationTaster and SIFT are benign and the nucleotide position is not strongly conserved by GERP++. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at